APPLICATIONS PUBLISHED 11 MAY 2005

Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic compsn in controlled release dosage forms as well as the corresponding method for providing this osmotic coating
Alza Corp 1528913*

Antigenic compsns
GlaxoSmithKline Biologicals 1528914*

Liposomal vaccine
Aphton Corp; Yissum Research Development Company of the Hebrew University of Jerusalem 1528915*

Multicomponent pharmaceutical dosage form
Glaxo Group 1528916*

Dosage from comprising high dose high soluble active ingredient as modified release active ingredient as immediate release
Torrent Pharmaceuticals 1528917*

Skin friendly active ingredient plaster based on SBC, containing at least 34 wt% of a pharmaceutical active ingredient and production thereof
Beiersdorf 1528918*

Therapeutic use of aryl amino acid derivatives
Pfizer 1528919*

Method for suppressing proliferation of abnormal prion protein with leucine, isoleucine or valine
Murayama, Yuuichi; Moriyama, Masami 1528920*

Methods for treatment and prevention of gastrointestinal conditions
Pharmacia 1528921*

Use of treosulphan and derivatives thereof for treating multiple sclerosis
Medac Gesellschaft fuer klinische Spezialpraeparate 1528922*

N-(3-oxo-2,3-dihydro-1H-isoindol-1-yl)acetyl)guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris
Aventis Pharma Deutschland 1528923*

MCHR1 antagonists
AstraZeneca 1528924*

Quinazoline derivatives for use in the treatment of cancer
AstraZeneca 1528925*

Novel pharmaceutical compsn of ceftiofur
Orchid Health Care; Ancare New Zealand 1528926*

Use of carboxamides for the treatment of tinnitus
Novartis 1528927*

Methods and compsns for modulating beta-catenin phophorylation
Yissum Research Development Company of the Hebrew University of Jerusalem 1528928*

Novel use of lipopeptide preparations Faculte Universitaire des Sciences Agronomiques de Gembloux; University of Liege 1528929*

Pharmaceutically active substance preparations and drugs that are capable of generating thrombin and/or that contain thrombin
Bio-Products& Bio-Engineering 1528930*

Methods for improving islet signalling in diabetes mellitus and for its prevention
Prosidion 1528931*

Novel motor protein of P Falciparum and methods for its use
Cytokinetics 1528932*

Pharmaceutical anti-TNF-alpha antibody formulation
Abbott Biotechnology 1528933*

Use of antibodies against a tumour-associated antigen
Igeneon Krebs-Immunotherapie Forschungs and Enwicklungs 1528934*

Methods for the treatment of an infectious bacterial disease with an anti-lactone derived signal molecules antibody
Haptogen 1528935*

Combination of tumour-associated surface protein antigens and tumour-associated sugars in the treatment and diagnosis of cancer
Igeneon Krebs-Immunotherapie Forschungs- und Entwicklungs 1528926*

Nanoemulsion vaccines
The Regents of the University of Michigan 1528927*

Synthesis of bone-polymer composite material
Osteotech 1528938*

Processing bag for component separator system and method for removing separated components
Zymequest 1528939*

Controlled release device and method
Microchips 1528940*

Device for programming a pump used to inject medicaments
Precimedix 1528941*

Derivatives of glycerinergic R(+)-2-amino-3-hydroxypropanoic acid
Prestwick Pharmaceuticals 1529030*

Acylated arylcycloalylamines and their use as pharmaceuticals
Aventis Pharma Deutschland 1529031*

Processes for the preparation of 4- 4- 4-(2-cyanoetheneyl)-2,6-dimethylphenyl)amino_-2-pyrimidinyl)amino benzonitrile
Janssen Pharmaceutica 1529032*

Integrated method for producing isocyanates
BASF 1529033*

Benzoylpyrazolones substituted by 3-aminocarbonyl
Bayer CropScience 1529034*

Crystalline (R)-2-(4-amindinophenylaminomethyl)-1-methyl-5-(1-carboxymethylamino)-1(pyrrolidino-carbonyl)-ethyl)-benzimidazole, and the use thereof as antithrombitic agents
Boehringer Ingelheim Pharma 1529035*

Method for producing highly pure crystalline 4-amino-5,6-dimethoxypyrimidine
Degussa 1529036*

Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
Genzyme 1529037*

Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
Novartis 1529038*

Method for producing maleic anhydride
BASF 1529039*

Endiandric acid H derivatives as C-MAF inhibitors for using against asthma
Aventis Pharma Deutschland 1529040*

Novel prodrugs of 1-methyl-2(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(N-2-pyridil-N-2-hydroxycarbonyl-ethyl)-amide, production and use thereof as medicaments
Boehringer Ingelheim Pharma 1529041*

Arylamides
Bayer HealthCare 1529042*

Novel process
Biovitrum 1529043*

Dehydrophenylahistins and analogues thereof and the synthesis of dehydrophenylahistins and analogues thereof
Nereus Pharmaceuticals 1529044*

New compounds
AstraZeneca 1529045*

Substituted benzimidazole compounds
Boehringer Ingelheim Pharma 1529046*

New purine derivatives
Cyclacel 1529047*

Methods for the synthesis of substituted purines
IRM; The Scripps Research Institute 1529048*

Derivatives of 2-trifluoromethyl-6-aminopurine as phosphodiesterase-4 inhibitors
Memory Pharmaceutical Corp 1529049*

Cephalosporins
Sandoz 1529050*

Group 4 metal complexes containing 4-aryl-substituted, tricyclic indenyl derivatives
Dow Global Technologies 1529051*

Licomycin derivatives possessing antibacterial activity
Vicuron Pharmaceuticals 1529052*

Macrolide compounds endowed with antiinflammatory activity
Zambon Group 1529053*

Therapeutic protein and treatments
Washington University 1529054*

Isolated nucleic acid molecule encoding a novel centomere-associated motor protein, and uses thereof
Merck 1529055*

Post-cleavage sulphur deprotection for convergent protein synthesis by chemical ligation
Geneprot 1529056*

Biphalin derivatives and their analgesic applications
Lipkowski, Andrzej; Carr, Daniel; Bonney, Iwona; Kosson, Dariusz; Misiecka-Kesik, Aleksandra 1529057*

A non-selective cation channel in neutral cells and methods for treating brain swelling
University of Maryland Baltimore 1529058*

Porcine leptin protein, antisense and antibody
Purina Mills; Purdue Research Foundation 1529059*

Method for the use of an immunostimulating mucin (MUC1)
Nemod Immunotherapie 1529060*

Method for isolating an intestinal cholesterol binding protein
Aventis Pharma Deutschland 1529061*

Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical WNT-signal transduction
Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts 1529062*

Antibodies anti-C5 component of the complement system and their use
Università Degli Studi di Trieste; Consiglio Nazionale Delle Ricerche 1529063*

Heterocyclic compound comprising a scaffold, an adjuvant and an antigen, and its use
Avidis 1529064*

Method for the controlled radical polymerisation of acrylic acid and the salts thereof, polymers thus obtained and applications thereof
Coatex 1529065*

Aid and method for processing thermoplastic compsns
Baerlocher 1529066*